BioCardia (BCDA) Price to Book (2015 - 2026)
BioCardia's (BCDA) quarterly Price to Book came in at 5.55 in Q2 2026, up 197.58% year-over-year from 1.87 in Q2 2025, and up 144.72% quarter-over-quarter from 12.42 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Price to Book (2015 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Price to Book for 12 consecutive years, with 5.55 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Book rose 197.58% year-over-year to 5.55 in Q2 2026; TTM through Jun 2026 was 5.55, a 197.58% increase from a year earlier, with the FY2025 full-year figure at 9.31, up 30.29% from the prior year.
- Price to Book was 5.55 for Q2 2026 at BioCardia, up from 12.42 in the prior quarter.
- Over five years, Price to Book peaked at 35.25 in Q2 2023 and troughed at 14.09 in Q3 2023.
- A 5-year average of 2.89 and a median of 3.51 in 2022 frame the typical range for Price to Book.
- The widest YoY moves for Price to Book: up 821.88% in 2023, down 266.72% in 2023.
- Over 5 years, Price to Book stood at 8.58 in 2022, then sank by 213.6% to 9.74 in 2023, then jumped by 173.34% to 7.15 in 2024, then surged by 30.29% to 9.31 in 2025, then plunged by 40.35% to 5.55 in 2026.
- The last three Price to Book figures came in at 5.55 (Q2 2026), 12.42 (Q1 2026), and 9.31 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.55 |
| Mar 31, 2026 | -12.42 |
| Dec 31, 2025 | 9.31 |
| Sep 30, 2025 | 3.08 |
| Jun 30, 2025 | -5.69 |
| Mar 31, 2025 | -7.82 |
| Dec 31, 2024 | 7.15 |
| Sep 30, 2024 | 3.20 |
| Jun 30, 2024 | -3.22 |
| Mar 31, 2024 | -4.84 |
| Dec 31, 2023 | -9.74 |
| Sep 30, 2023 | -14.09 |
| Jun 30, 2023 | 35.25 |
| Mar 31, 2023 | 20.73 |
| Dec 31, 2022 | 8.58 |
| Sep 30, 2022 | 8.45 |
| Jun 30, 2022 | 3.82 |
| Mar 31, 2022 | 4.74 |
| Dec 31, 2021 | 3.15 |
| Sep 30, 2021 | 3.95 |